BDRX · Biodexa Pharmaceuticals Plc
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Apr 6, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Apr 6, 2026.
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BDRX
this stock
Biodexa Pharmaceuticals Plc
|
$872,647 | — | — | — | 0.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.42B | +20.5% | +46.2% | 31.8 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.22B | +7.2% | +20.8% | 20.5 | 2.3% |
|
ARGX
Argenx SE
|
$64.25B | +22.9% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$60.55B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 1.5%
- Net QoQ
- -58.5K sh
- Top holder
- ARMISTICE CAPITAL, LLC
Performance
Raw-price comparisons begin at the captured split on Apr 6, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BDRX | -2.3% | -44.9% | — | +4.4% | — |
| SPY | +0.1% | -0.4% | +15.1% | +0.4% | +12.9% |
| vs SPY | -2.4% | -44.5% | — | +4.0% | — |